234 related articles for article (PubMed ID: 37072718)
1. Fungal infection profile in critically ill COVID-19 patients: a prospective study at a large teaching hospital in a middle-income country.
Negm EM; Mohamed MS; Rabie RA; Fouad WS; Beniamen A; Mosallem A; Tawfik AE; Salama HM
BMC Infect Dis; 2023 Apr; 23(1):246. PubMed ID: 37072718
[TBL] [Abstract][Full Text] [Related]
2. Bacterial coinfection in critically ill COVID-19 patients with severe pneumonia.
Elabbadi A; Turpin M; Gerotziafas GT; Teulier M; Voiriot G; Fartoukh M
Infection; 2021 Jun; 49(3):559-562. PubMed ID: 33393065
[TBL] [Abstract][Full Text] [Related]
3. Bacterial and fungal superinfections are detected at higher frequency in critically ill patients affected by SARS CoV-2 infection than negative patients and are associated to a worse outcome.
De Francesco MA; Signorini L; Piva S; Pellizzeri S; Fumarola B; Corbellini S; Piccinelli G; Simonetti F; Carta V; Mangeri L; Padovani M; Vecchiati D; Latronico N; Castelli F; Caruso A
J Med Virol; 2023 Jul; 95(7):e28892. PubMed ID: 37394790
[TBL] [Abstract][Full Text] [Related]
4. An overview of COVID-19 related to fungal infections: what do we know after the first year of pandemic?
Vitale RG; Afeltra J; Seyedmousavi S; Giudicessi SL; Romero SM
Braz J Microbiol; 2022 Jun; 53(2):759-775. PubMed ID: 35315001
[TBL] [Abstract][Full Text] [Related]
5. [Respiratory infections caused by Aspergillus spp. in critically ill patients admitted to the intensive care units].
Álvarez Lerma F; Olaechea Astigarraga P; Palomar Martínez M; Rodríguez Carvajal M; Machado Casas JF; Jiménez Quintana MM; Esteve Urbano F; Ballesteros Herráez JC; Zavala Zegarra E;
Med Intensiva; 2015 Apr; 39(3):149-59. PubMed ID: 24713089
[TBL] [Abstract][Full Text] [Related]
6. Coinfection and superinfection in ICU critically ill patients with severe COVID-19 pneumonia and influenza pneumonia: are the pictures different?
Chen Z; Zhan Q; Huang L; Wang C
Front Public Health; 2023; 11():1195048. PubMed ID: 37711242
[TBL] [Abstract][Full Text] [Related]
7. COVID-19-Associated Pulmonary Aspergillosis, Fungemia, and Pneumocystosis in the Intensive Care Unit: a Retrospective Multicenter Observational Cohort during the First French Pandemic Wave.
Bretagne S; Sitbon K; Botterel F; Dellière S; Letscher-Bru V; Chouaki T; Bellanger AP; Bonnal C; Fekkar A; Persat F; Costa D; Bourgeois N; Dalle F; Lussac-Sorton F; Paugam A; Cassaing S; Hasseine L; Huguenin A; Guennouni N; Mazars E; Le Gal S; Sasso M; Brun S; Cadot L; Cassagne C; Cateau E; Gangneux JP; Moniot M; Roux AL; Tournus C; Desbois-Nogard N; Le Coustumier A; Moquet O; Alanio A; Dromer F;
Microbiol Spectr; 2021 Oct; 9(2):e0113821. PubMed ID: 34668768
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 associated Pulmonary Aspergillosis in Patients Admitted to the Intensive Care Unit: Impact of Antifungal Prophylaxis.
Frost J; Gornicec M; Reisinger AC; Eller P; Hoenigl M; Prattes J
Mycopathologia; 2024 Jan; 189(1):3. PubMed ID: 38217742
[TBL] [Abstract][Full Text] [Related]
9. Secondary infection in COVID-19 critically ill patients: a retrospective single-center evaluation.
De Bruyn A; Verellen S; Bruckers L; Geebelen L; Callebaut I; De Pauw I; Stessel B; Dubois J
BMC Infect Dis; 2022 Mar; 22(1):207. PubMed ID: 35236299
[TBL] [Abstract][Full Text] [Related]
10. COVID-19-associated mucormycosis: a systematic review and meta-analysis of 958 cases.
Özbek L; Topçu U; Manay M; Esen BH; Bektas SN; Aydın S; Özdemir B; Khostelidi SN; Klimko N; Cornely O; Zakhour J; Kanj SS; Seidel D; Hoenigl M; Ergönül Ö
Clin Microbiol Infect; 2023 Jun; 29(6):722-731. PubMed ID: 36921716
[TBL] [Abstract][Full Text] [Related]
11. Co-infection and ICU-acquired infection in COIVD-19 ICU patients: a secondary analysis of the UNITE-COVID data set.
Conway Morris A; Kohler K; De Corte T; Ercole A; De Grooth HJ; Elbers PWG; Povoa P; Morais R; Koulenti D; Jog S; Nielsen N; Jubb A; Cecconi M; De Waele J;
Crit Care; 2022 Aug; 26(1):236. PubMed ID: 35922860
[TBL] [Abstract][Full Text] [Related]
12. Respiratory co-infections in COVID-19-positive patients.
M Abd El-Halim R; Hafez H; Albahet I; Sherif B
Eur J Med Res; 2023 Sep; 28(1):317. PubMed ID: 37660059
[TBL] [Abstract][Full Text] [Related]
13. Bacterial and fungal co-infections among COVID-19 patients in intensive care unit.
Yang S; Hua M; Liu X; Du C; Pu L; Xiang P; Wang L; Liu J
Microbes Infect; 2021; 23(4-5):104806. PubMed ID: 33684520
[TBL] [Abstract][Full Text] [Related]
14. COVID-19-associated fungal infections.
Hoenigl M; Seidel D; Sprute R; Cunha C; Oliverio M; Goldman GH; Ibrahim AS; Carvalho A
Nat Microbiol; 2022 Aug; 7(8):1127-1140. PubMed ID: 35918423
[TBL] [Abstract][Full Text] [Related]
15. Bacterial and fungal ventilator associated pneumonia in critically ill COVID-19 patients during the second wave.
Meawed TE; Ahmed SM; Mowafy SMS; Samir GM; Anis RH
J Infect Public Health; 2021 Oct; 14(10):1375-1380. PubMed ID: 34420902
[TBL] [Abstract][Full Text] [Related]
16. Invasive fungal infections in critically ill patients: A prospective study from a tertiary care hospital in India.
Durga CS; Gupta N; Soneja M; Bhatt M; Xess I; Jorwal P; Singh G; Ray A; Nischal N; Ranjan P; Biswas A; Wig N
Drug Discov Ther; 2018; 12(6):363-367. PubMed ID: 30674771
[TBL] [Abstract][Full Text] [Related]
17. A National Strategy to Diagnose Coronavirus Disease 2019-Associated Invasive Fungal Disease in the Intensive Care Unit.
White PL; Dhillon R; Cordey A; Hughes H; Faggian F; Soni S; Pandey M; Whitaker H; May A; Morgan M; Wise MP; Healy B; Blyth I; Price JS; Vale L; Posso R; Kronda J; Blackwood A; Rafferty H; Moffitt A; Tsitsopoulou A; Gaur S; Holmes T; Backx M
Clin Infect Dis; 2021 Oct; 73(7):e1634-e1644. PubMed ID: 32860682
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology, diagnosis and treatment of fungal respiratory infections in the critically ill patient.
Garnacho-Montero J; Olaechea P; Alvarez-Lerma F; Alvarez-Rocha L; Blanquer J; Galván B; Rodriguez A; Zaragoza R; Aguado JM; Mensa J; Solé A; Barberán J
Rev Esp Quimioter; 2013 Jun; 26(2):173-88. PubMed ID: 23817660
[TBL] [Abstract][Full Text] [Related]
19. The Impact of Corticosteroids on Secondary Infection and Mortality in Critically Ill COVID-19 Patients.
Ritter LA; Britton N; Heil EL; Teeter WA; Murthi SB; Chow JH; Ricotta E; Chertow DS; Grazioli A; Levine AR
J Intensive Care Med; 2021 Oct; 36(10):1201-1208. PubMed ID: 34247526
[TBL] [Abstract][Full Text] [Related]
20. Mucormycosis and COVID-19 pandemic: Clinical and diagnostic approach.
Azhar A; Khan WH; Khan PA; Alhosaini K; Owais M; Ahmad A
J Infect Public Health; 2022 Apr; 15(4):466-479. PubMed ID: 35216920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
